The global electrical stimulation market for spinal fusion was valued at over $610 million in 2024.
The market is projected to grow at a CAGR of 4.4%, reaching over $820 million by 2031.
The market report covers the following two anatomical segments:
- Cervical Electrical Stimulation Devices
- Lumbar Electrical Stimulation Devices
Market Data Included
- Unit Sales
- Average Selling Prices (ASPs)
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts to 2031
- Historical Data to 2024
- Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitor Insights
Global Spinal Electrical Stimulation Market Trends
- Growing adoption of minimally invasive spinal fusion procedures is driving the use of electrical stimulators in outpatient settings.
- Surge in development and interest around next-generation stimulation technologies, including:
- Wireless control systems
- Patient-specific programming features
- These advances aim to improve compliance, efficacy, and convenience for patients recovering from spinal fusion surgeries.
Global Spinal Electrical Stimulation Market Share Insights
- 1 Orthofix
- Maintained the leading global position in 2024, capturing over 50% of the total market share.
- Held dominant positions in both cervical and lumbar segments, particularly in North America and Western Europe.
- Strength attributed to brand trust, extensive clinical support, and broad global adoption.
- 2 ZimVie (Highridge Medical)
- Ranked second globally, with over one-fifth of total market share.
- Strong presence in Western Europe and emerging markets within the Rest of the World.
- Focused portfolio tailored for spinal fusion stimulation contributed to market expansion.
- 3 Enovis
- Held the third-largest share in the global spinal electrical stimulation market in 2024.
- Strong performance in North America and maintained presence globally.
- Continued R&D investment and a diversified orthopedic product portfolio supported its competitive positioning.
Market Segmentation Summary
- By Anatomy:
- Cervical Electrical Stimulation Devices
- Lumbar Electrical Stimulation Devices
Global Research Scope
- Regions Covered
- North America: Canada, United States
- Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
- Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
- Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
- Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
- Asia-Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
- Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Data
- Procedure Volumes
- Market Size
- Market Share by Company and Segment
- Forecasted Market Growth Rates
- Unit Sales
- Average Selling Prices
Qualitative Data
- Emerging Market Trends
- Limiting Factors
- Competitive Landscape
- Mergers & Acquisitions
- Product Portfolios
- FDA Recalls and Safety Events
- Disruptive Technologies
Data Sources
- Primary Interviews with Industry Leaders
- Government and Regulatory Agency Data
- Hospital Procurement Data
- Import & Export Logs
- iData Research Internal Databases